Financials
- Market Capitalization 570.23 M
- Employee 21
- Founded 2012
- CEO N/A
- Website www.immixbio.com
- Headquarter Delaware, United States
- FIGI BBG00HLCWH09
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2800 | FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 11.55 USD | -1.28% | -8.48% | +25.68% | +2.21% | 603.79 M USD | ||
| 2839 | ALT Altimmune, Inc. - Common Stock | 2.99 USD | +2.05% | -1.32% | +12.83% | -28.81% | 581.48 M USD | ||
| 2843 | DRUG Bright Minds Biosciences Inc. - common stock | 76.75 USD | +3.67% | +17.37% | +28.82% | +209.85% | 586.05 M USD | ||
| 2855 | DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 9.06 USD | +0.11% | +1.91% | +11.44% | +2.03% | 564.66 M USD |
Frequently asked questions about Immix Biopharma, Inc. - Common Stock
What is the Immix Biopharma, Inc. - Common Stock stock price today?
The current price of Immix Biopharma, Inc. - Common Stock (IMMX) is 10.48. Over the past 24 hours, the stock has changed by -1.87%. Follow the IMMX chart for real-time price dynamics.
What is the stock ticker of Immix Biopharma, Inc. - Common Stock?
Immix Biopharma, Inc. - Common Stock trades under the ticker IMMX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Immix Biopharma, Inc. - Common Stock stock going up?
IMMX has changed by -3.76% over the last week, +23.29% over the last month, and +271.63% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Immix Biopharma, Inc. - Common Stock net income for the last quarter?
Immix Biopharma, Inc. - Common Stock reported net income of -10.09 M for the last quarter. The previous quarter showed -10.69 M, which means net income changed by +5.62%.
How many employees does Immix Biopharma, Inc. - Common Stock have?
As of the latest available data, Immix Biopharma, Inc. - Common Stock has 21 employees. Workforce size can provide additional context about the company's scale and operations.
What is Immix Biopharma, Inc. - Common Stock EBITDA?
Immix Biopharma, Inc. - Common Stock EBITDA is -10.7 M, and its EBITDA margin is 45.51 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Immix Biopharma, Inc. - Common Stock stock?
You can buy Immix Biopharma, Inc. - Common Stock (IMMX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Immix Biopharma, Inc. - Common Stock stock?
Investing in Immix Biopharma, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IMMX chart and related analysis on metatrader.com as part of your research.